Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

William J. Elliott

AddressChicago IL 60637
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Carlisle SE, Howard LT, Nazarchyk JC, Elliott WJ. Reducing the Expenditures and Workload Associated With VA Partial-Fill Prescription Processing. Fed Pract. 2018 Apr; 35(4):28-33. PMID: 30766351.
      View in: PubMed
    2. Messerli FH, Hofstetter L, Agabiti-Rosei E, Burnier M, Elliott WJ, Franklin SS, Grodzicki T, Kario K, Kjeldsen SE, Kostis JB, Laurent S, Leenen FH, de Leeuw PW, Lund-Johansen P, Mancia G, Narkiewicz K, Papademetriou V, Parati G, Poulter N, Redon J, Rimoldi SF, Ruilope LM, Schiffrin EL, Schmieder RE, Schwartz AB, Sever P, Sowers JR, Staessen JA, Wang J, Weber M, Williams B. Reply. J Hypertens. 2017 11; 35(11):2327-2328. PMID: 28953595.
      View in: PubMed
    3. Elliott WJ, Bistrika EA. Perindopril arginine and amlodipine besylate for hypertension: a safety evaluation. Expert Opin Drug Saf. 2018 Feb; 17(2):207-216. PMID: 29065722.
      View in: PubMed
    4. Cheng W, Singh N, Elliott W, Lee J, Rassoolkhani A, Jin X, McFarland EW, Mubeen S. Earth-Abundant Tin Sulfide-Based Photocathodes for Solar Hydrogen Production. Adv Sci (Weinh). 2018 01; 5(1):1700362. PMID: 29375966.
      View in: PubMed
    5. Roush GC, Perez F, Abdelfattah R, Prindle A, Jean E, Singh T, Kostis JB, Kostis WJ, Elliott WJ, Berlin JA. Quality of Meta-Analyses for Randomized Trials in the Field of Hypertension: an Updated and Improved Systematic Review. Curr Hypertens Rep. 2017 Sep; 19(9):71. PMID: 28785887.
      View in: PubMed
    6. Messerli FH, Hofstetter L, Agabiti-Rosei E, Burnier M, Elliott WJ, Franklin SS, Grodzicki T, Kario K, Kjeldsen SE, Kostis JB, Laurent S, Leenen FH, Lund-Johansen P, Mancia G, Narkiewicz K, Papademetriou V, Parati G, Poulter N, Redon J, Rimoldi SF, Ruilope LM, Schiffrin EL, Schmieder RE, Schwartz AB, Sever P, Sowers JR, Staessen JA, Wang J, Weber M, Williams B, de Leeuw PW. Expertise: no longer a sine qua non for guideline authors? J Hypertens. 2017 08; 35(8):1564-1566. PMID: 28657972.
      View in: PubMed
    7. Messerli FH, Hofstetter L, Agabiti-Rosei E, Burnier M, Elliott WJ, Franklin SS, Grodzicki T, Kario K, Kjeldsen SE, Kostis JB, Laurent S, Leenen FH, Lund-Johansen P, Mancia G, Narkiewicz K, Papademetriou V, Parati G, Poulter N, Redon J, Rimoldi SF, Ruilope LM, Schiffrin EL, Schmieder RE, Schwartz AB, Sever P, Sowers JR, Staessen JA, Wang J, Weber M, Williams B. Expertise: No Longer a Sine Qua Non for Guideline Authors? Hypertension. 2017 08; 70(2):235-237. PMID: 28652465.
      View in: PubMed
    8. Roush GC, Amante B, Singh T, Ayele H, Araoye M, Yang D, Kostis WJ, Elliott WJ, Kostis JB, Berlin JA. Quality of meta-analyses for randomized trials in the field of hypertension: a systematic review. J Hypertens. 2016 12; 34(12):2305-2317. PMID: 27755384.
      View in: PubMed
    9. Jurca SJ, Elliott WJ. Common Substances That May Contribute to Resistant Hypertension, and Recommendations for Limiting Their Clinical Effects. Curr Hypertens Rep. 2016 10; 18(10):73. PMID: 27671491.
      View in: PubMed
    10. Elliott WJ, Jurca S. Loop diuretics are most appropriate for hypertension treatment in chronic kidney disease. J Am Soc Hypertens. 2016 Apr; 10(4):285-7. PMID: 26993218.
      View in: PubMed
    11. Elliott WJ. Perindopril arginine + amlodipine for the treatment of hypertension in the USA. Expert Opin Pharmacother. 2015; 16(14):2217-29. PMID: 26325023.
      View in: PubMed
    12. Rosendorff C, Lackland DT, Allison M, Aronow WS, Black HR, Blumenthal RS, Cannon CP, de Lemos JA, Elliott WJ, Findeiss L, Gersh BJ, Gore JM, Levy D, Long JB, O'Connor CM, O'Gara PT, Ogedegbe G, Oparil S, White WB. Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. Hypertension. 2015 Jun; 65(6):1372-407. PMID: 25828847.
      View in: PubMed
    13. Rosendorff C, Lackland DT, Allison M, Aronow WS, Black HR, Blumenthal RS, Cannon CP, de Lemos JA, Elliott WJ, Findeiss L, Gersh BJ, Gore JM, Levy D, Long JB, O'Connor CM, O'Gara PT, Ogedegbe G, Oparil S, White WB. Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. Circulation. 2015 May 12; 131(19):e435-70. PMID: 25829340.
      View in: PubMed
    14. Rosendorff C, Lackland DT, Allison M, Aronow WS, Black HR, Blumenthal RS, Cannon CP, de Lemos JA, Elliott WJ, Findeiss L, Gersh BJ, Gore JM, Levy D, Long JB, O'Connor CM, O'Gara PT, Ogedegbe O, Oparil S, White WB. Treatment of Hypertension in Patients With Coronary Artery Disease: A Scientific Statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. J Am Coll Cardiol. 2015 May 12; 65(18):1998-2038. PMID: 25840655.
      View in: PubMed
    15. Rosendorff C, Lackland DT, Allison M, Aronow WS, Black HR, Blumenthal RS, Cannon CP, de Lemos JA, Elliott WJ, Findeiss L, Gersh BJ, Gore JM, Levy D, Long JB, O'Connor CM, O'Gara PT, Ogedegbe O, Oparil S, White WB. Treatment of hypertension in patients with coronary artery disease: A scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. J Am Soc Hypertens. 2015 Jun; 9(6):453-98. PMID: 25840695.
      View in: PubMed
    16. Elliott WJ, Whitmore J, Feldstein JD, Bakris GL. Efficacy and safety of perindopril arginine + amlodipine in hypertension. J Am Soc Hypertens. 2015 Apr; 9(4):266-74. PMID: 25804495.
      View in: PubMed
    17. Elliott WJ. Treatment: drug therapy of hypertension. J Am Soc Hypertens. 2015 Mar; 9(3):239-41; quiz 242-3. PMID: 25795551.
      View in: PubMed
    18. Elliott WJ. Rationale for a single-pill combination of perindopril arginine and amlodipine besylate. J Am Soc Hypertens. 2015 Apr; 9(4):257-65. PMID: 25817217.
      View in: PubMed
    19. Randhawa SK, Elliott WJ. Therapy: atenolol versus metoprolol tartrate--conflicting outcomes data. Nat Rev Nephrol. 2014 Nov; 10(11):617-8. PMID: 25201142.
      View in: PubMed
    20. Elliott WJ, Brook RD. Response to Call for a re-evaluation of the American Heart Association's standpoint concerning device-guided slow breathing using the RESPeRATE device. Hypertension. 2013 Oct; 62(4):e18. PMID: 24156102.
      View in: PubMed
    21. Cooper-DeHoff RM, Elliott WJ. Generic drugs for hypertension: are they really equivalent? Curr Hypertens Rep. 2013 Aug; 15(4):340-5. PMID: 23700299.
      View in: PubMed
    22. Brook RD, Appel LJ, Rubenfire M, Ogedegbe G, Bisognano JD, Elliott WJ, Fuchs FD, Hughes JW, Lackland DT, Staffileno BA, Townsend RR, Rajagopalan S. Beyond medications and diet: alternative approaches to lowering blood pressure: a scientific statement from the american heart association. Hypertension. 2013 Jun; 61(6):1360-83. PMID: 23608661.
      View in: PubMed
    23. Elliott WJ, Egan B, Giles TD, Bakris GL, White WB, Sansone TM. Rationale for establishing a mechanism to increase reimbursement to hypertension specialists. J Clin Hypertens (Greenwich). 2013 Jun; 15(6):397-403. PMID: 23730988.
      View in: PubMed
    24. Gorelick PB, Nyenhuis D. Blood pressure and treatment of persons with hypertension as it relates to cognitive outcomes including executive function. J Am Soc Hypertens. 2012 Sep-Oct; 6(5):309-15. PMID: 22995799.
      View in: PubMed
    25. Elliott WJ. 'Hot topics' in hypertension. Curr Opin Cardiol. 2012 Jul; 27(4):368-9. PMID: 22565139.
      View in: PubMed
    26. Roberie DR, Elliott WJ. What is the prevalence of resistant hypertension in the United States? Curr Opin Cardiol. 2012 Jul; 27(4):386-91. PMID: 22596184.
      View in: PubMed
    27. Elliott WJ. Effects of potassium-sparing versus thiazide diuretics on glucose tolerance: new data on an old topic. Hypertension. 2012 May; 59(5):911-2. PMID: 22493076.
      View in: PubMed
    28. Elliott WJ, Childers WK. Should ß blockers no longer be considered first-line therapy for the treatment of essential hypertension without comorbidities? Curr Cardiol Rep. 2011 Dec; 13(6):507-16. PMID: 21898116.
      View in: PubMed
    29. Elliott WJ, Ram CV. Calcium channel blockers. J Clin Hypertens (Greenwich). 2011 Sep; 13(9):687-9. PMID: 21896151.
      View in: PubMed
    30. Elliott WJ. What should be the blood pressure target for diabetic patients? Curr Opin Cardiol. 2011 Jul; 26(4):308-13. PMID: 21597367.
      View in: PubMed
    31. Elliott WJ. High prevalence of white-coat hypertension in Spanish resistant hypertensive patients. Hypertension. 2011 May; 57(5):889-90. PMID: 21444834.
      View in: PubMed
    32. Elliott WJ, Basu S, Meyer PM. Network meta-analysis of heart failure prevention by antihypertensive drugs. Arch Intern Med. 2011 Mar 14; 171(5):472; author reply 472-3. PMID: 21403048.
      View in: PubMed
    33. Elliott WJ. Do the blood pressure effects of nonsteroidal antiinflammatory drugs influence cardiovascular morbidity and mortality? Curr Hypertens Rep. 2010 Aug; 12(4):258-66. PMID: 20524091.
      View in: PubMed
    34. Elliott WJ. Hypertension. Curr Opin Cardiol. 2010 Jul; 25(4):340-1. PMID: 20535069.
      View in: PubMed
    35. Maitland ML, Bakris GL, Black HR, Chen HX, Durand JB, Elliott WJ, Ivy SP, Leier CV, Lindenfeld J, Liu G, Remick SC, Steingart R, Tang WH. Initial assessment, surveillance, and management of blood pressure in patients receiving vascular endothelial growth factor signaling pathway inhibitors. J Natl Cancer Inst. 2010 May 05; 102(9):596-604. PMID: 20351338.
      View in: PubMed
    36. Maitland ML, Kasza KE, Karrison T, Moshier K, Sit L, Black HR, Undevia SD, Stadler WM, Elliott WJ, Ratain MJ. Ambulatory monitoring detects sorafenib-induced blood pressure elevations on the first day of treatment. Clin Cancer Res. 2009 Oct 01; 15(19):6250-7. PMID: 19773379.
      View in: PubMed
    37. Elliott WJ. Improving outcomes in hypertensive patients: focus on adherence and persistence with antihypertensive therapy. J Clin Hypertens (Greenwich). 2009 Jul; 11(7):376-82. PMID: 19583634.
      View in: PubMed
    38. Elliott WJ, Grimm RH. Using diuretics in practice--one opinion. J Clin Hypertens (Greenwich). 2008 Nov; 10(11):856-62. PMID: 19128275.
      View in: PubMed
    39. Elliott WJ. Renovascular hypertension: an update. J Clin Hypertens (Greenwich). 2008 Jul; 10(7):522-33. PMID: 18607138.
      View in: PubMed
    40. Elliott WJ. What factors contribute to the inadequate control of elevated blood pressure? J Clin Hypertens (Greenwich). 2008 Jan; 10(1 Suppl 1):20-6. PMID: 18174780.
      View in: PubMed
    41. Elliott WJ, Black HR. Prehypertension. Nat Clin Pract Cardiovasc Med. 2007 Oct; 4(10):538-48. PMID: 17893682.
      View in: PubMed
    42. Elliott WJ. Systemic hypertension. Curr Probl Cardiol. 2007 Apr; 32(4):201-59. PMID: 17398315.
      View in: PubMed
    43. Messerli F, Frishman WH, Elliott WJ, Bacher PH, Pepine CJ. Antihypertensive properties of a high-dose combination of trandolapril and verapamil-SR. Blood Press Suppl. 2007 Mar; 1:6-9. PMID: 17566313.
      View in: PubMed
    44. Elliott WJ, Young PE, DeVivo L, Feldstein J, Black HR. A comparison of two sphygmomanometers that may replace the traditional mercury column in the healthcare workplace. Blood Press Monit. 2007 Feb; 12(1):23-8. PMID: 17303984.
      View in: PubMed
    45. Elliott WJ, Meyer PM. Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet. 2007 Jan 20; 369(9557):201-7. PMID: 17240286.
      View in: PubMed
    46. Elliott WJ, Plauschinat CA, Skrepnek GH, Gause D. Persistence, adherence, and risk of discontinuation associated with commonly prescribed antihypertensive drug monotherapies. J Am Board Fam Med. 2007 Jan-Feb; 20(1):72-80. PMID: 17204738.
      View in: PubMed
    47. Elliott WJ. Drug interactions and drugs that affect blood pressure. J Clin Hypertens (Greenwich). 2006 Oct; 8(10):731-7. PMID: 17028488.
      View in: PubMed
    48. Elliott WJ, Izzo JL. Device-guided breathing to lower blood pressure: case report and clinical overview. MedGenMed. 2006 Aug 01; 8(3):23. PMID: 17406163.
      View in: PubMed
    49. Sever PS, Poulter NR, Elliott WJ, Jonsson MC, Black HR, Sever PS, Poulter NR, Elliott WJ, Jonsson MC, Black HR. Blood pressure reduction is not the only determinant of outcome. Circulation. 2006 Jun 13; 113(23):2754-72; discussion 2773-4. PMID: 16769926.
      View in: PubMed
    50. Elliott WJ. Clinical features in the management of selected hypertensive emergencies. Prog Cardiovasc Dis. 2006 Mar-Apr; 48(5):316-25. PMID: 16627047.
      View in: PubMed
    51. Elliott WJ, Hewkin AC, Kupfer S, Cooper-DeHoff R, Pepine CJ. A drug dose model for predicting clinical outcomes in hypertensive coronary disease patients. J Clin Hypertens (Greenwich). 2005 Nov; 7(11):654-63. PMID: 16278523.
      View in: PubMed
    52. Choi KL, Elliott WJ. Antihypertensive, antiproteinuric therapy and myocardial infarction and stroke prevention. Curr Hypertens Rep. 2005 Oct; 7(5):367-73. PMID: 16157081.
      View in: PubMed
    53. Elliott WJ. Differential effects of antihypertensive drugs on new-onset diabetes? Curr Hypertens Rep. 2005 Aug; 7(4):249-56. PMID: 16061042.
      View in: PubMed
    54. Elliott WJ. Cardiovascular events in hypertension trials of Angiotensin-converting enzyme inhibitors. J Clin Hypertens (Greenwich). 2005 Aug; 7(8 Suppl 2):2-4. PMID: 16106130.
      View in: PubMed
    55. Garg JP, Ellis R, Elliott WJ, Hasabou N, Chua D, Chertow GM, Bakris GL. Angiotensin receptor blockade and arterial compliance in chronic kidney disease: a pilot study. Am J Nephrol. 2005 Jul-Aug; 25(4):393-9. PMID: 16088080.
      View in: PubMed
    56. Khosla N, Chua DY, Elliott WJ, Bakris GL. Are chlorthalidone and hydrochlorothiazide equivalent blood-pressure-lowering medications? J Clin Hypertens (Greenwich). 2005 Jun; 7(6):354-6. PMID: 16088299.
      View in: PubMed
    57. Christensen JG, Vincent PW, Klohs WD, Fry DW, Leopold WR, Elliott WL. Plasma vascular endothelial growth factor and interleukin-8 as biomarkers of antitumor efficacy of a prototypical erbB family tyrosine kinase inhibitor. Mol Cancer Ther. 2005 Jun; 4(6):938-47. PMID: 15956251.
      View in: PubMed
    58. Black HR, Elliott WJ, Grandits G, Grambsch P, Lucente T, Neaton JD, Grimm RH, Hansson L, Lacourcière Y, Muller JE, Sleight P, Weber MA, White WB, Williams GH, Wittes J, Zanchetti A, Anders RJ. Results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial by geographical region. J Hypertens. 2005 May; 23(5):1099-106. PMID: 15834298.
      View in: PubMed
    59. Garg JP, Elliott WJ, Folker A, Izhar M, Black HR. Resistant hypertension revisited: a comparison of two university-based cohorts. Am J Hypertens. 2005 May; 18(5 Pt 1):619-26. PMID: 15882544.
      View in: PubMed
    60. Elliott WJ, Bandari A. The role of calcium antagonists in stroke prevention. J Clin Hypertens (Greenwich). 2005 Apr; 7(4 Suppl 1):5-8. PMID: 15858396.
      View in: PubMed
    61. Elliott WJ. Management of hypertension in the very elderly patient. Hypertension. 2004 Dec; 44(6):800-4. PMID: 15505119.
      View in: PubMed
    62. Choi KL, Chua D, Elliott WJ. Chlorthalidone vs other low-dose diuretics. JAMA. 2004 Oct 20; 292(15):1816-7; author reply 1817. PMID: 15494575.
      View in: PubMed
    63. Elliott WJ. Clinical features and management of selected hypertensive emergencies. J Clin Hypertens (Greenwich). 2004 Oct; 6(10):587-92. PMID: 15470289.
      View in: PubMed
    64. Hanley D, Gorelick PB, Elliott WJ, Broder MS, Saver JL, Kidwell CS, Fagan SC, Wilson A, Lennihan L, Schwer WA, Rubenstein LZ, Crowell RM, Haines SJ, Lopez CC, Zorowitz R, Dubois RW. Determining the appropriateness of selected surgical and medical management options in recurrent stroke prevention: a guideline for primary care physicians from the National Stroke Association work group on recurrent stroke prevention. J Stroke Cerebrovasc Dis. 2004 Sep-Oct; 13(5):196-207. PMID: 17903976.
      View in: PubMed
    65. Menzin J, Lang K, Elliott WJ, Boulanger L, Arocho R, Tran MH, Friedman M. Adherence to calcium channel blocker therapy in older adults: a comparison of amlodipine and felodipine. J Int Med Res. 2004 May-Jun; 32(3):233-9. PMID: 15174215.
      View in: PubMed
    66. Elliott WJ. Management of hypertension emergencies. Curr Hypertens Rep. 2003 Dec; 5(6):486-92. PMID: 14594569.
      View in: PubMed
    67. Elliott WJ. Compliance--and improving it--in hypertension. Manag Care. 2003 Aug; 12(8 Suppl Hypertension):56-61. PMID: 12971594.
      View in: PubMed
    68. Elliott WJ. The economic impact of hypertension. J Clin Hypertens (Greenwich). 2003 May-Jun; 5(3 Suppl 2):3-13. PMID: 12826765.
      View in: PubMed
    69. Black HR, Elliott WJ, Grandits G, Grambsch P, Lucente T, White WB, Neaton JD, Grimm RH, Hansson L, Lacourciere Y, Muller J, Sleight P, Weber MA, Williams G, Wittes J, Zanchetti A, Anders RJ. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. JAMA. 2003 Apr 23-30; 289(16):2073-82. PMID: 12709465.
      View in: PubMed
    70. Furumoto-Dawson Al, Pandey DK, Elliott WJ, de Leon Mendes CF, Al-Hani AJ, Hollenberg S, Camba N, Wicklund R, Black HR. Hypertension in women: the Women Take Heart project. J Clin Hypertens (Greenwich). 2003 Jan-Feb; 5(1):38-46. PMID: 12556652.
      View in: PubMed
    71. Prisant LM, Elliott WJ. Drug delivery systems for treatment of systemic hypertension. Clin Pharmacokinet. 2003; 42(11):931-40. PMID: 12908851.
      View in: PubMed
    72. Carter BL, Zillich AJ, Elliott WJ. How pharmacists can assist physicians with controlling blood pressure. J Clin Hypertens (Greenwich). 2003 Jan-Feb; 5(1):31-7. PMID: 12556651.
      View in: PubMed
    73. Elliott WJ. Optimizing medication adherence in older persons with hypertension. Int Urol Nephrol. 2003; 35(4):557-62. PMID: 15198166.
      View in: PubMed
    74. Neutel J, Elliott WJ, Izzo J, Chen CL, Masonson H. Antihypertensive efficacy of olmesartan medoxomil, a new angiotensin II receptor antagonist, as assessed by ambulatory blood pressure measurements. J Clin Hypertens (Greenwich). 2002 Sep-Oct; 4(5):325-31. PMID: 12368570.
      View in: PubMed
    75. Elliott WJ. Is fixed combination therapy appropriate for initial hypertension treatment? Curr Hypertens Rep. 2002 Aug; 4(4):278-85. PMID: 12117454.
      View in: PubMed
    76. Hogan TJ, Elliott WJ, Seto AH, Bakris GL. Antihypertensive treatment with and without benazepril in patients with chronic renal insufficiency: a US economic evaluation. Pharmacoeconomics. 2002; 20(1):37-47. PMID: 11817991.
      View in: PubMed
    77. White WB, Johnson MF, Anders RJ, Elliott WJ, Black HR. Safety of controlled-onset extended-release verapamil in middle-aged and older patients with hypertension and coronary artery disease. Am Heart J. 2001 Dec; 142(6):1010-5. PMID: 11717605.
      View in: PubMed
    78. White WB, Johnson MF, Black HR, Elliott WJ, Sica DA. Gender and age effects on the ambulatory blood pressure and heart rate responses to antihypertensive therapy. Am J Hypertens. 2001 Dec; 14(12):1239-47. PMID: 11775133.
      View in: PubMed
    79. Black HR, Elliott WJ, Weber MA, Frishman WH, Strom JA, Liebson PR, Hwang CT, Ruff DA, Montoro R, DeQuattro V, Zhang D, Schleman MM, Klibaner MI. One-year study of felodipine or placebo for stage 1 isolated systolic hypertension. Hypertension. 2001 Nov; 38(5):1118-23. PMID: 11711508.
      View in: PubMed
    80. Sica DA, Elliott WJ. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in combination: theory and practice. J Clin Hypertens (Greenwich). 2001 Nov-Dec; 3(6):383-7. PMID: 11723362.
      View in: PubMed
    81. Elliott WJ, Calhoun DA, DeLucca PT, Gazdick LP, Kerns DE, Zeldin RK. Losartan versus valsartan in the treatment of patients with mild to moderate essential hypertension: data from a multicenter, randomized, double-blind, 12-week trial. Clin Ther. 2001 Aug; 23(8):1166-79. PMID: 11558856.
      View in: PubMed
    82. Elliott WJ. Timing treatment to the rhythm of disease. A short course in chronotherapeutics. Postgrad Med. 2001 Aug; 110(2):119-22, 125-6, 129. PMID: 11787411.
      View in: PubMed
    83. Elliott WJ. Hypertensive emergencies. Crit Care Clin. 2001 Apr; 17(2):435-51. PMID: 11450325.
      View in: PubMed
    84. White WB, Elliott WJ, Johnson MF, Black HR. Chronotherapeutic delivery of verapamil in obese versus non-obese patients with essential hypertension. J Hum Hypertens. 2001 Feb; 15(2):135-41. PMID: 11317194.
      View in: PubMed
    85. Elliott WJ, Black HR. Calcium antagonists in hypertension. Blood Press. 2001; 10(5-6):387-97. PMID: 11822541.
      View in: PubMed
    86. Black HR, Elliott WJ, Neaton JD, Grandits G, Grambsch P, Grimm RH, Hansson L, Lacoucière Y, Muller J, Sleight P, Weber MA, White WB, Williams G, Wittes J, Zanchetti A, Fakouhi TD, Anders RJ. Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial. Hypertension. 2001 Jan; 37(1):12-18. PMID: 11208750.
      View in: PubMed
    87. Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R, Tuttle K, Douglas J, Hsueh W, Sowers J. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis. 2000 Sep; 36(3):646-61. PMID: 10977801.
      View in: PubMed
    88. Elliott WJ. Therapeutic trials comparing angiotensin converting enzyme inhibitors and angiotensin II receptor blockers. Curr Hypertens Rep. 2000 Aug; 2(4):402-11. PMID: 10981176.
      View in: PubMed
    89. Elliott WJ. Blood pressure and death from coronary heart disease. N Engl J Med. 2000 Jun 01; 342(22):1676. PMID: 10836883.
      View in: PubMed
    90. Elliott WJ, Weir DR, Black HR. Cost-effectiveness of the lower treatment goal (of JNC VI) for diabetic hypertensive patients. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 2000 May 08; 160(9):1277-83. PMID: 10809030.
      View in: PubMed
    91. Elliott WJ, Maddy R, Toto R, Bakris G. Hypertension in patients with diabetes. Overcoming barriers to effective control. Postgrad Med. 2000 Mar; 107(3):29-32, 35-6, 38. PMID: 10728133.
      View in: PubMed
    92. Elliott WJ. When will the ACE-inhibitors be declared obsolete? J Hum Hypertens. 2000 Feb; 14(2):79-81. PMID: 10723111.
      View in: PubMed
    93. Carter BL, Elliott WJ. The role of pharmacists in the detection, management, and control of hypertension: a national call to action. Pharmacotherapy. 2000 Feb; 20(2):119-22. PMID: 10678289.
      View in: PubMed
    94. Swan S, Elliott WJ, Bakris G. "Clinical pharmacology studies in patients with renal impairment: past experience and regulatory perspectives". J Clin Pharmacol. 2000 Jan; 40(1):7-10. PMID: 10631617.
      View in: PubMed
    95. Elliott WJ, Weir DR. Comparative cost-effectiveness of HMG-CoA reductase inhibitors in secondary prevention of acute myocardial infarction. Am J Health Syst Pharm. 1999 Sep 01; 56(17):1726-32. PMID: 10512503.
      View in: PubMed
    96. Elliott WJ. Intensive antihypertensive treatment to the new lower blood pressure targets. Curr Hypertens Rep. 1999 Aug; 1(4):313-9. PMID: 10981083.
      View in: PubMed
    97. Elliott WJ, Toth SJ, Stemer A, Cadwalader JH. Detection, treatment, and control of adult hypertension in northwest Indiana. Ispat Inland/United Steelworkers of America Health Care Network. Am J Hypertens. 1999 Aug; 12(8 Pt 1):830-4. PMID: 10480478.
      View in: PubMed
    98. Elliott WJ, Montoro R, Smith D, Leibowitz M, Hwang C, Gradman AH, Schleman M, Klibaner M. Comparison of two strategies for intensifying antihypertensive treatment: low-dose combination (enalapril + felodipine ER) versus increased dose of monotherapy (enalapril). LEVEL (Lexxel vs Enalapril) Study Group. Am J Hypertens. 1999 Jul; 12(7):691-6. PMID: 10411366.
      View in: PubMed
    99. Elliott WJ. Which blood pressure measurement is more important in the elderly? Arch Intern Med. 1999 Jun 14; 159(11):1165-6. PMID: 10371222.
      View in: PubMed
    100. Elliott WJ. Double-blind comparison of eprosartan and enalapril on cough and blood pressure in unselected hypertensive patients. Eprosartan Study Group. J Hum Hypertens. 1999 Jun; 13(6):413-7. PMID: 10408592.
      View in: PubMed
    101. Elliott WJ. Circadian variation in blood pressure: implications for the elderly patient. Am J Hypertens. 1999 Feb; 12(2 Pt 2):43S-49S. PMID: 10090294.
      View in: PubMed
    102. Elliott WJ. Traditional drug therapy of hypertension in transplant recipients. J Hum Hypertens. 1998 Dec; 12(12):845-9. PMID: 9883707.
      View in: PubMed
    103. Black HR, Elliott WJ, Neaton JD, Grandits G, Grambsch P, Grimm RH, Hansson L, Lacoucière Y, Muller J, Sleight P, Weber MA, White WB, Williams G, Wittes J, Zanchetti A, Fakouhi TD. Rationale and design for the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Trial. Control Clin Trials. 1998 Aug; 19(4):370-90. PMID: 9683312.
      View in: PubMed
    104. Elliott WJ. Circadian variation in the timing of stroke onset: a meta-analysis. Stroke. 1998 May; 29(5):992-6. PMID: 9596248.
      View in: PubMed
    105. Kassler-Taub K, Littlejohn T, Elliott W, Ruddy T, Adler E. Comparative efficacy of two angiotensin II receptor antagonists, irbesartan and losartan in mild-to-moderate hypertension. Irbesartan/Losartan Study Investigators. Am J Hypertens. 1998 Apr; 11(4 Pt 1):445-53. PMID: 9607383.
      View in: PubMed
    106. Messerli F, Frishman WH, Elliott WJ. Effects of verapamil and trandolapril in the treatment of hypertension. Trandolapril Study Group. Am J Hypertens. 1998 Mar; 11(3 Pt 1):322-7. PMID: 9544873.
      View in: PubMed
    107. White WB, Black HR, Weber MA, Elliott WJ, Bryzinski B, Fakouhi TD. Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate-blood pressure product. Am J Cardiol. 1998 Feb 15; 81(4):424-31. PMID: 9485131.
      View in: PubMed
    108. Elliott WJ. Blood pressure tracking. J Cardiovasc Risk. 1997 Aug; 4(4):251-6. PMID: 9477201.
      View in: PubMed
    109. Elliott WJ, Black HR. Rationale and benefits of classification of hypertension severity. Curr Opin Cardiol. 1997 Jul; 12(4):368-74. PMID: 9263648.
      View in: PubMed
    110. Elliott WJ. Higher incidence of discontinuation of angiotensin converting enzyme inhibitors due to cough in black subjects. Clin Pharmacol Ther. 1996 Nov; 60(5):582-8. PMID: 8941032.
      View in: PubMed
    111. Saseen JJ, Carter BL, Brown TE, Elliott WJ, Black HR. Comparison of nifedipine alone and with diltiazem or verapamil in hypertension. Hypertension. 1996 Jul; 28(1):109-14. PMID: 8675249.
      View in: PubMed
    112. Elliott WJ. The costs of treating hypertension: what are the long-term realities of cost containment and pharmacoeconomics? Postgrad Med. 1996 Apr; 99(4):241-8, 251-2. PMID: 8604411.
      View in: PubMed
    113. Elliott WJ. ALLHAT: the largest and most important clinical trial in hypertension ever done in the USA. Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial. Am J Hypertens. 1996 Apr; 9(4 Pt 1):409-11. PMID: 8722446.
      View in: PubMed
    114. Elliott WJ. The costs of treating hypertension. Postgrad Med. 1996 Apr; 99(4):241-252. PMID: 29231117.
      View in: PubMed
    115. Elliott WJ, Powell LH. Diagonal earlobe creases and prognosis in patients with suspected coronary artery disease. Am J Med. 1996 Feb; 100(2):205-11. PMID: 8629656.
      View in: PubMed
    116. Elliott WJ. Glucose and cholesterol elevations during thiazide therapy: intention-to-treat versus actual on-therapy experience. Am J Med. 1995 Sep; 99(3):261-9. PMID: 7653486.
      View in: PubMed
    117. Elliott WJ. An individualized approach to the hypertensive patient with renal disease: six illustrative case studies. J Clin Pharmacol. 1995 Jan; 35(1):98-102. PMID: 7751418.
      View in: PubMed
    118. Elliott WJ. Cardiovascular risk factors. Postgrad Med. 1994 Sep; 96(3):49-61. PMID: 29211560.
      View in: PubMed
    119. Elliott WJ. Cardiovascular risk factors. Which ones can and should be remedied? Postgrad Med. 1994 Sep 01; 96(3):49-50, 53-4, 58 passim. PMID: 8072914.
      View in: PubMed
    120. Carter BL, Frohlich ED, Elliott WJ, Moore MA, Mann RJ, Roberts RW. Selected factors that influence responses to antihypertensives. Choosing therapy for the uncomplicated patient. Arch Fam Med. 1994 Jun; 3(6):528-36. PMID: 7915943.
      View in: PubMed
    121. Elliott WJ. Compliance strategies. Curr Opin Nephrol Hypertens. 1994 May; 3(3):271-8. PMID: 7922252.
      View in: PubMed
    122. Elliott WJ. Antihypertensive therapy in a patient with gout and asthma. JAMA. 1994 Feb 16; 271(7):555. PMID: 8301774.
      View in: PubMed
    123. Elliott WJ. Controversies regarding the recommendations of the Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Compr Ther. 1994; 20(3):181-5. PMID: 8187460.
      View in: PubMed
    124. Shusterman NH, Elliott WJ, White WB. Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function. Am J Med. 1993 Aug; 95(2):161-8. PMID: 8102835.
      View in: PubMed
    125. Elliott WJ, Martin WB, Murphy MB. Comparison of two noninvasive screening tests for renovascular hypertension. Arch Intern Med. 1993 Mar 22; 153(6):755-64. PMID: 8447713.
      View in: PubMed
    126. Oliner CM, Elliott WJ, Gretler DD, Murphy MB. Low predictive value of positive Osler manoeuvre for diagnosing pseudohypertension. J Hum Hypertens. 1993 Feb; 7(1):65-70. PMID: 8450523.
      View in: PubMed
    127. Gretler DD, Elliott WJ, Moscucci M, Childers RW, Murphy MB. Electrocardiographic changes during acute treatment of hypertensive emergencies with sodium nitroprusside or fenoldopam. Arch Intern Med. 1992 Dec; 152(12):2445-8. PMID: 1360793.
      View in: PubMed
    128. Elliott WJ, Karrison T. Increased all-cause and cardiac morbidity and mortality associated with the diagonal earlobe crease: a prospective cohort study. Am J Med. 1991 Sep; 91(3):247-54. PMID: 1892144.
      View in: PubMed
    129. Elliott WJ, Geppert E. Development of a successful fourth-year medical school elective course in therapeutics. Clin Pharmacol Ther. 1991 Sep; 50(3):249-53. PMID: 1914358.
      View in: PubMed
    130. Elliott WJ, Weber RR, Murphy MB. A double-blind, randomized, placebo-controlled comparison of the metabolic effects of low-dose hydrochlorothiazide and indapamide. J Clin Pharmacol. 1991 Aug; 31(8):751-7. PMID: 1880234.
      View in: PubMed
    131. Elliott WJ, Murphy MB, Karp R. Long-term preservation of renal function in hypertensive heart transplant recipients treated with enalapril and a diuretic. J Heart Lung Transplant. 1991 May-Jun; 10(3):373-9. PMID: 1854764.
      View in: PubMed
    132. Gretler DD, Gramelspacher GP, Fumo MT, Elliott WJ, Murphy MB. Influence of diuretic therapy on the clonidine suppression test. J Clin Pharmacol. 1991 May; 31(5):448-54. PMID: 2050831.
      View in: PubMed
    133. Elliott WJ, Karnezis TA, Silverman RA, Geanon J, Tripathi RC, Murphy MB. Intraocular pressure increases with fenoldopam, but not nitroprusside, in hypertensive humans. Clin Pharmacol Ther. 1991 Mar; 49(3):285-93. PMID: 1672512.
      View in: PubMed
    134. Elliott WJ, Polascik TB, Murphy MB. Equivalent antihypertensive effects of combination therapy using diuretic + calcium antagonist compared with diuretic + ACE inhibitor. J Hum Hypertens. 1990 Dec; 4(6):717-23. PMID: 2096214.
      View in: PubMed
    135. Elliott WJ, Weber RR, Nelson KS, Oliner CM, Fumo MT, Gretler DD, McCray GR, Murphy MB. Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertension. Circulation. 1990 Mar; 81(3):970-7. PMID: 1968368.
      View in: PubMed
    136. Murphy MB, Elliott WJ. Dopamine and dopamine receptor agonists in cardiovascular therapy. Crit Care Med. 1990 Jan; 18(1 Pt 2):S14-8. PMID: 1967161.
      View in: PubMed
    137. Elliott WJ, Murphy MB, Straus FH, Jarabak J. Improved safety of glucagon testing for pheochromocytoma by prior alpha-receptor blockade. A controlled trial in a patient with a mixed ganglioneuroma/pheochromocytoma. Arch Intern Med. 1989 Jan; 149(1):214-6. PMID: 2912409.
      View in: PubMed
    138. Nelson KS, Weber RR, Elliott WJ, Zebrauskas D, Murphy MB. Evaluation of the Suntech Accutracker. A novel noninvasive ambulatory blood pressure monitor. Am J Hypertens. 1988 Jul; 1(3 Pt 3):121S-123S. PMID: 3415784.
      View in: PubMed
    139. Elliott WJ, Murphy MB. Reduced specificity of the clonidine suppression test in patients with normal plasma catecholamine levels. Am J Med. 1988 Mar; 84(3 Pt 1):419-24. PMID: 3348244.
      View in: PubMed
    140. Bakris GL, Weber RR, Nelson K, Elliott WJ, Kaplan E, Murphy MB. Comparison of the effects of dopamine and fenoldopam, a selective dopamine-1 agonist, on parathyroid hormone release in man. Miner Electrolyte Metab. 1988; 14(6):343-6. PMID: 2906737.
      View in: PubMed
    141. Donnelly PK, Lennard TW, Proud G, Taylor RM, Henderson R, Fletcher K, Elliott W, Ward MK, Wilkinson R. Continuous ambulatory peritoneal dialysis and renal transplantation: a five year experience. Br Med J (Clin Res Ed). 1985 Oct 12; 291(6501):1001-4. PMID: 3931765.
      View in: PubMed
    142. Elliott WJ. Ear lobe crease and coronary artery disease. 1,000 patients and review of the literature. Am J Med. 1983 Dec; 75(6):1024-32. PMID: 6359874.
      View in: PubMed
    Elliott's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Physical Neighbors Expand Description
    _